We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma.
- Authors
Reardon, D A; Dresemann, G; Taillibert, S; Campone, M; van den Bent, M; Clement, P; Blomquist, E; Gordower, L; Schultz, H; Raizer, J; Hau, P; Easaw, J; Gil, M; Tonn, J; Gijtenbeek, A; Schlegel, U; Bergstrom, P; Green, S; Weir, A; Nikolova, Z
- Abstract
We evaluated the efficacy of imatinib mesylate in addition to hydroxyurea in patients with recurrent glioblastoma (GBM) who were either on or not on enzyme-inducing anti-epileptic drugs (EIAEDs).
- Publication
British journal of cancer, 2009, Vol 101, Issue 12, p1995
- ISSN
1532-1827
- Publication type
Journal Article
- DOI
10.1038/sj.bjc.6605411